Cargando…

MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia

Multiple targeted therapies are currently explored for pediatric and young adult B-cell precursor acute lymphoblastic leukemia (BCP-ALL) treatment. However, this new armamentarium of therapies faces an old problem: choosing the right treatment for each patient. The lack of predictive biomarkers is p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manzano-Muñoz, Albert, Alcon, Clara, Menéndez, Pablo, Ramírez, Manuel, Seyfried, Felix, Debatin, Klaus-Michael, Meyer, Lüder H., Samitier, Josep, Montero, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458912/ https://www.ncbi.nlm.nih.gov/pubmed/34568318 http://dx.doi.org/10.3389/fcell.2021.695225

Ejemplares similares

ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins
por: Alcon, Clara, et al.
Publicado: (2021)

MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment
por: Alcon, Clara, et al.
Publicado: (2022)

The Role of Mcl-1 in Embryonic Neural Precursor Cell Apoptosis
por: Flemmer, Robert T., et al.
Publicado: (2021)

P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Sun, Qian, et al.
Publicado: (2023)

Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL
por: Seyfried, Felix, et al.
Publicado: (2022)

The Anti-apoptotic Role of 3′-Untranslational Region in Response to Angiotensin II via Mcl1 Expression
por: Lyu, Dayin, et al.
Publicado: (2021)

Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
por: Lázaro-Navarro, Juan, et al.
Publicado: (2021)

Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance
por: Alcon, Clara, et al.
Publicado: (2020)

Physiological Functions of Mcl-1: Insights From Genetic Mouse Models
por: Chin, Hui San, et al.
Publicado: (2021)

Upregulation of Mcl-1S Causes Cell-Cycle Perturbations and DNA Damage Accumulation
por: Streletskaia, Alena Y., et al.
Publicado: (2020)

Non-Apoptotic Role of Apoptotic Caspases in the Drosophila Nervous System
por: Colon-Plaza, Sarah, et al.
Publicado: (2022)

miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
por: Li, Ming, et al.
Publicado: (2021)

FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function
por: Coccia, Elena, et al.
Publicado: (2022)

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

A Reverse-Osmosis Model of Apoptotic Shrinkage
por: Rana, Priyanka S., et al.
Publicado: (2020)

Ions, the Movement of Water and the Apoptotic Volume Decrease
por: Bortner, Carl D., et al.
Publicado: (2020)

Control of mitochondrial dynamics and apoptotic pathways by peroxisomes
por: Jiang, Chenxing, et al.
Publicado: (2022)

Role of transcription factors in apoptotic cells clearance
por: Gao, Yuqiong, et al.
Publicado: (2023)

Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2019)

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)

Non-Canonical Roles of Apoptotic Caspases in the Nervous System
por: Dehkordi, Mahshid H., et al.
Publicado: (2022)

The Ubiquitin-Proteasome System in Apoptosis and Apoptotic Cell Clearance
por: Yuan, Lei, et al.
Publicado: (2022)

Bok: real killer or bystander with non-apoptotic roles?
por: Bonzerato, Caden G., et al.
Publicado: (2023)

Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023)

Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
por: Burke, Matthew R., et al.
Publicado: (2022)

Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases
por: Luo, Meng-Yi, et al.
Publicado: (2021)

Cancer as a mitochondrial metabolic disease
por: Seyfried, Thomas N.
Publicado: (2015)

Exercise-induced signaling pathways to counteracting cardiac apoptotic processes
por: Pahlavani, Hamed Alizadeh
Publicado: (2022)

Chemokines and phosphatidylserine: New binding partners for apoptotic cell clearance
por: Pontejo, Sergio M., et al.
Publicado: (2022)

Editorial: Non-apoptotic cell death mechanisms and their therapeutic significance
por: Lopus, Manu, et al.
Publicado: (2022)

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
por: Ogana, Heather A., et al.
Publicado: (2023)

The progress in the relationship between trace elements and acute lymphoblastic leukemia
por: Wang, Jing, et al.
Publicado: (2023)

Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
por: Ianza, Anna, et al.
Publicado: (2021)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Editorial: Adopting drug repurposing to overcome drug resistance in cancer
por: Shankar, Eswar, et al.
Publicado: (2023)

The Earliest T-Precursors in the Mouse Embryo Are Susceptible to Leukemic Transformation
por: Ding, Jixin, et al.
Publicado: (2021)

Allosteric Inhibition of Anti-Apoptotic MCL-1
por: Lee, Susan, et al.
Publicado: (2016)

Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia
por: Qian, Jiabi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hhl983panccdduo8tk6kif80a8